News

Compassion Center and SIDHE Research Institute Take the Lead in Ethical Hallucinogen Research to Revolutionize Mental Health Treatment

Compassion Center and SIDHE Research Institute are pioneering a new era of mental health care through ethical hallucinogen research. By…

1 year ago

MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA

MIAMI, FL / ACCESSWIRE / September 11, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing…

1 year ago

At Park Mental Health, Clients Are Given Customized Plans for the Most Effective Treatment on Their Road to Recovery

SAN DIEGO, CA / ACCESSWIRE / September 11, 2024 / Park Mental Health specializes in working with clients dealing with…

1 year ago

Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota

Expanded cleanroom and improved distribution facilities enhance manufacturing capacity and shipping efficiencies ANN ARBOR, MI / ACCESSWIRE / September 11,…

1 year ago

PharmAla to supply Johns Hopkins Medicine for Clinical Trial

TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology…

1 year ago

VPR Brands Continues Aggressive Patent Enforcement With New Infringement Cases and Strategic Efforts for Future Protection

VPR Brands Aims to Drive the Next Wave of Growth in the Vaping Industry While Ensuring That Our Technologies Set…

1 year ago

Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market

Company taps Comercial Medico Quirurigca, SA and Durgalab as first EU distributors for its CE-marked women’s reproductive healthcare productsATLANTA, Sept.…

1 year ago

Veru to Present at the 2024 Cantor Global Healthcare Conference

MIAMI, FL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

1 year ago

SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline

FORT LAUDERDALE, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII),…

1 year ago